Clinical profile, treatment assignment, predictors of death of patients with severe symptomatic aortic stenosis not eligible to participate in a clinical trial evaluation of transcatheter aortic valve implantation




Background


Transcatheter aortic valve implantation (TAVI) technology is currently evaluated in patients with severe aortic stenosis (AS) who are considered high-risk surgical candidates. This study aimed to detect the incidence, cause, and correlates of mortality in patients who were not eligible to participate in the TAVI study.




Methods


From April 2007 to July 2009, a cohort of 362 patients with severe AS were screened and did not meet the inclusion/exclusion criteria to participate in the TAVI trial. These patients were assigned into two groups: I—medical arm, 274 (75.7%) [treated medically: 97 (35.4%) or by balloon aortic valvuloplasty (BAV): 177 (64.6%)]; and II—surgical arm, 88 (24.3%). Clinical follow-up was obtained by telephone contact or office visit.




Methods


From April 2007 to July 2009, a cohort of 362 patients with severe AS were screened and did not meet the inclusion/exclusion criteria to participate in the TAVI trial. These patients were assigned into two groups: I—medical arm, 274 (75.7%) [treated medically: 97 (35.4%) or by balloon aortic valvuloplasty (BAV): 177 (64.6%)]; and II—surgical arm, 88 (24.3%). Clinical follow-up was obtained by telephone contact or office visit.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Clinical profile, treatment assignment, predictors of death of patients with severe symptomatic aortic stenosis not eligible to participate in a clinical trial evaluation of transcatheter aortic valve implantation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access